316 related articles for article (PubMed ID: 25806106)
1. Immunotherapeutic approaches to ovarian cancer treatment.
Chester C; Dorigo O; Berek JS; Kohrt H
J Immunother Cancer; 2015; 3():7. PubMed ID: 25806106
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy in ovarian cancer.
Krishnan V; Berek JS; Dorigo O
Curr Probl Cancer; 2017; 41(1):48-63. PubMed ID: 28169004
[TBL] [Abstract][Full Text] [Related]
3. Rationale for chemotherapy, immunotherapy, and checkpoint blockade in SCLC: beyond traditional treatment approaches.
Spigel DR; Socinski MA
J Thorac Oncol; 2013 May; 8(5):587-98. PubMed ID: 23546044
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy for ovarian cancer: recent advances and perspectives.
Zsiros E; Tanyi J; Balint K; Kandalaft LE
Curr Opin Oncol; 2014 Sep; 26(5):492-500. PubMed ID: 25036883
[TBL] [Abstract][Full Text] [Related]
5. Integrating Cancer Vaccines in the Standard-of-Care of Ovarian Cancer: Translating Preclinical Models to Human.
Chiang CL; Rovelli R; Sarivalasis A; Kandalaft LE
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572778
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy.
Amedei A; Niccolai E; Prisco D
Hum Vaccin Immunother; 2014; 10(11):3354-68. PubMed ID: 25483688
[TBL] [Abstract][Full Text] [Related]
7. Development of Therapeutic Vaccines for Ovarian Cancer.
Chow S; Berek JS; Dorigo O
Vaccines (Basel); 2020 Nov; 8(4):. PubMed ID: 33167428
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy in Ovarian Cancer.
Siminiak N; Czepczyński R; Zaborowski MP; Iżycki D
Arch Immunol Ther Exp (Warsz); 2022 Aug; 70(1):19. PubMed ID: 35941287
[TBL] [Abstract][Full Text] [Related]
9. Immune modulations during chemoimmunotherapy & novel vaccine strategies--in metastatic melanoma and non small-cell lung cancer.
Iversen TZ
Dan Med J; 2013 Dec; 60(12):B4774. PubMed ID: 24355457
[TBL] [Abstract][Full Text] [Related]
10. Prospects of combinatorial synthetic peptide vaccine-based immunotherapy against cancer.
Arens R; van Hall T; van der Burg SH; Ossendorp F; Melief CJ
Semin Immunol; 2013 Apr; 25(2):182-90. PubMed ID: 23706598
[TBL] [Abstract][Full Text] [Related]
11. Strategies for Cancer Immunotherapy Using Induced Pluripotency Stem Cells-Based Vaccines.
Bernardes de Jesus B; Neves BM; Ferreira M; Nóbrega-Pereira S
Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33266109
[TBL] [Abstract][Full Text] [Related]
12. Cancer immunotherapy: harnessing the immune system to battle cancer.
Yang Y
J Clin Invest; 2015 Sep; 125(9):3335-7. PubMed ID: 26325031
[TBL] [Abstract][Full Text] [Related]
13. Clinically feasible approaches to potentiating cancer cell-based immunotherapies.
Seledtsov VI; Goncharov AG; Seledtsova GV
Hum Vaccin Immunother; 2015; 11(4):851-69. PubMed ID: 25933181
[TBL] [Abstract][Full Text] [Related]
14. [Immunotherapy: new insights].
Geissler M; Weth R
Praxis (Bern 1994); 2002 Dec; 91(51-52):2236-46. PubMed ID: 12564040
[TBL] [Abstract][Full Text] [Related]
15. Immune checkpoint modulation: rational design of combination strategies.
Zamarin D; Postow MA
Pharmacol Ther; 2015 Jun; 150():23-32. PubMed ID: 25583297
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapeutic and oncolytic viral therapeutic strategies in pancreatic cancer.
Khan ML; Halfdanarson TR; Borad MJ
Future Oncol; 2014 May; 10(7):1255-75. PubMed ID: 24947264
[TBL] [Abstract][Full Text] [Related]
17. Strategies and Advancements in Harnessing the Immune System for Gastric Cancer Immunotherapy.
Subhash VV; Yeo MS; Tan WL; Yong WP
J Immunol Res; 2015; 2015():308574. PubMed ID: 26579545
[TBL] [Abstract][Full Text] [Related]
18. Novel immunotherapeutic strategies in gynecologic oncology. Dendritic cell-based immunotherapy for ovarian cancer.
Santin AD; Bellone S; Underwood LJ; O'Brien TJ; Ravaggi A; Pecorelli S; Cannon MJ
Minerva Ginecol; 2002 Apr; 54(2):133-44. PubMed ID: 12032451
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapeutic Approaches in Ovarian Cancer.
Yoon H; Kim A; Jang H
Curr Issues Mol Biol; 2023 Feb; 45(2):1233-1249. PubMed ID: 36826026
[TBL] [Abstract][Full Text] [Related]
20. New developments in immunotherapy for lymphoma.
Heyman B; Yang Y
Cancer Biol Med; 2018 Aug; 15(3):189-209. PubMed ID: 30197788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]